Short answer
Twist Bioscience Corp (TWST) filed an 8-K current report with the SEC on August 19, 2026 reporting Item 7.01 (Regulation FD Disclosure). Anthropic selected Twist as an independent evaluator for AI-designed protein production and binding tests.
Twist Bioscience Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Anthropic selected Twist as an independent evaluator for AI-designed protein production and binding tests
- Campaign spans 15 protein targets using Claude Opus 4.8 and Mythos Preview
- Strategic validation of Twist’s rapid, scaled DNA synthesis and protein-testing capabilities
- Potential demand upside from AI-enabled drug discovery, though financial terms and commercial commitments remain unspecified
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Twist Bioscience Corp 8-K filings
Get the next TWST 8-K as it lands
Follow TWST for push alerts, or ask the research agent what this filing means.